⌘K

Home/Filings/4/0001213900-19-003738

4//SEC Filing

Berger Mark Stanley 4

Accession 0001213900-19-003738

CIK 0001388320other

View on SEC.gov Company Profile

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 4:15 PM ET

Size

4.5 KB

Accession

0001213900-19-003738

Insider Transaction Report

Form 4

Period: 2019-03-05

Actinium Pharmaceuticals, Inc.ATNM

Berger Mark Stanley

Chief Medical Officer

Transactions

Exercise of In-Money
Common Stock
2019-03-05$0.60/sh+3,500$2,100→ 22,500 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

Actinium Pharmaceuticals, Inc.

CIK 0001388320

Entity typeother

Related Parties

1

filerCIK 0001700283

Filing Metadata

Form type: 4
Filed: Mar 6, 7:00 PM ET
Accepted: Mar 7, 4:15 PM ET
Size: 4.5 KB

View on SEC.gov